Premier Alternatives

GelMEDIX

Cambridge, MA · Founded 2020 · Privately Held (backing)

Developer of a light-activated biomaterial platform designed to bring innovation in ocular and regenerative therapies. GelMEDIX is based in Cambridge, MA and was founded in 2020. It was valued at $21 million at its seed round in Feb 2026, the last priced event on record. It has raised $30.7 million across 4 recorded rounds; the latest was a $747,000 seed round in Oct 2025.

PMV mark · valuation
$21.0M
Oct 2026
Priced at
its seed round
Feb 2026
Total raised
$30.7M
Last round
Seed Round
Oct 2025

GelMEDIX key facts

as of Oct 2026
  • Developer of a light-activated biomaterial platform designed to bring innovation in ocular and regenerative therapies.
  • GelMEDIX is valued at approximately $21.0M as of Oct 2026, set at its seed round, Feb 2026; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $30.7M across 4 recorded rounds; the latest was Seed Round ($747K) in Oct 2025.
  • Notable investors include Safar Partners, Beacon Angels, TiE Angels Boston, Boston Harbor Angels, EQx Fund — 6 tracked in total.
  • GelMEDIX has filed 6 Form Ds with the SEC since 2020, most recently Apr 2026 ($747K sold to 5 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
MEDIUM confidence
$21.0M

Valued at $21.0M at its seed round, Feb 2026. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of GelMEDIX with a free account
  • ·Watch GelMEDIX: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

GelMEDIX funding rounds

4 rounds
Oct 2025Seed Round$747KSEC filing▮
Jan 2025Seed Round$1.0MSEC filing▮
Mar 2024Debt$1.9MSEC filing▮
Jun 2020Early Stage VC$6.4MSEC filing▮
Full funding history →

GelMEDIX valuation

GelMEDIX was valued at $21 million at its seed round in Feb 2026. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has GelMEDIX raised?

GelMEDIX has raised $30.7 million in total; 4 of its rounds are on record, from 2020 on. The largest on record was a $747,000 seed round in Oct 2025.

GelMEDIX has filed 6 Form Ds with the SEC since 2020, most recently in Apr 2026 ($747,000 sold to 5 investors).

GelMEDIX investors

6 investors are on record for GelMEDIX, including Safar Partners, Beacon Angels, TiE Angels Boston and Boston Harbor Angels. The seed round in Oct 2025 drew 5 investors.

About GelMEDIX

Developer of a light-activated biomaterial platform designed to bring innovation in ocular and regenerative therapies. The company's platform focuses on bio-adhesion, tissue regeneration, tunable mechanics and therapeutic loading across modalities from small molecules to cell and gene therapies through its photo-crosslinked hydrogels, enabling medical professionals to perform cell-based therapies for vision restoration, intraocular sustained release of small molecules and peptides and in situ forming bioadhesives.

Sector
Healthcare
HQ
Cambridge, MA, United States
Founded
2020
Employees
5
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.